Clinical Trials

Latest Headlines

Latest Headlines

Gartner researcher: Wearables not ready for limelight in clinical trials

Mobile health wearables aren't ready to play a starring role in clinical trials, according to Gartner Research Director Michael Shanler, despite all the attention the devices have seen recently.

FDA looks to improve its use of IT for clinical investigations

The U.S. Food and Drug Administration, attempting to improve its clinical investigation processes, established a public docket last week to solicit feedback on how healthcare stakeholders are using technology for such research efforts.

Computational model compares disease societal cost vs. research funding

University of Chicago researchers have developed a computational model to improve the allocation of U.S. biomedical research resources.

Big data from EHRs bolsters drug research

With the help of big data, researchers have discovered that the combination of two drugs can significantly lower patients' blood pressure, according to a study published in the  Journal of General Internal Medicine.

David Lee Scher: Physicians, consumers must capitalize on mHealth tools

Mobile healthcare tech adoption is lagging for more than a few reasons, writes health technology consultant David Lee Scher, M.D., despite the fact big name tech companies are investing in the market.

FDA: EHRs can help get 'medicines to market faster'

The U.S. Food and Drug Administration has shed further light on why it wants electronic health records to be part of drug trials, acknowledging that it may spur the use of electronic source data and speed up the drug approval process.

FDA to explore use of EHRs to aid in drug trials

The U.S. Food and Drug Administration has announced its interest in considering the use of electronic health records with electronic data capture in order to improve clinical trials for new and investigational drugs.

Researchers examine balancing privacy risk, utility of de-identified health data

Researchers have shown how easy it is to re-identify patients in de-identified data, yet de-identified data can lose its value as more identifying factors are stripped out.

Precision medicine will require transparent software, 'exquisite' data

Figuring out how to piece together data from a hodgepodge of clinical studies will be one of the first items on the agenda for President Barack Obama's Precision Medicine initiative, according to Francis Collins, director of the National Institutes of Health.

Washington biobank plan raises ethical concerns

The University of Washington health system and Seattle Cancer Care Alliance plan to start seeking patient consent to have medical records and leftover blood or tissue made available for future research.